Navigation Links
EU Drug Regulator Highlights Depression Danger of Weight-loss Pill

The European drug regulator EMEA said Thursday it had maintained authorisation of weight-loss pill Acomplia in the European Union, but had ordered it to be withheld from people suffering from depression.

A panel of experts from the US Food and Drug Administration concluded in June that the dieting treatment, which can also be used to treat diabetes, was unsafe because it caused suicidal thoughts as a side-effect.

The maker of the drug, French group Sanofi-Aventis, abandoned attempts to win approval for the drug in the United States as a result.

The European Medicines Agency (EMEA) recommended Thursday that Acomplia, also known as Rimonabant, should not be given to patients with depression or those taking anti-depressants because of the risk of psychiatric side-effects.

The agency said that depression was known as the main side-effect of the drug and this had been signalled at the time of its approval in June 2006.

However, the Agency's Committee for Medicinal Products for Human Use (CHMP) had recommended upgrading the warning about depression.

Sanofi-Aventis, the fourth-biggest drug maker in the world, announced afterwards that it had changed its labelling to take into account the EMEA's comments.

The recommendation from the EMEA will be sent to doctors prescribing drugs in the countries where the drug in being sold.


'"/>




Page: 1

Related medicine news :

1. US Regulator Sees No Link Between Tamiflu And Japan Deaths
2. Tumor Suppressor p53s Contradictory Regulatory System
3. A brush with the U.S. Regulators can cost a fortune
4. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
5. Human Complexity Can Be Attributed To Regulatory Sequence
6. Regulators Object Drug Produced from Genetically Engineered Farm Animals
7. The Lancet Calls For Review Of Regulatory Process Of Drug Trials
8. Medtronic’s Insulin Pump Receives Regulatory Approva
9. Australian Drug Regulators Call for Revamp On The Pharmaceutical Surveillance
10. Drug Regulators Need To Think In Long-Term, Say Charities
11. Regulatory T-cells – Protector or Cause of Diseases
Post Your Comments:
(Date:10/15/2008)... Will Educate Parents about Prescription,Drug Abus...mily Partnership (NFP),has designated Monday, Octo...g off the group,s 23rd annual Red Ribbon Week from...ents with action steps to prevent children,s,presc...million teens in the United States abuse,prescript...
(Date:10/14/2008)...4 /PRNewswire-USNewswire/ -- Kerby T.,Alvy, Ph.D.,...r for the,Improvement in North Hollywood (CICC), h... and Prevention (CDC) to serve as an expert to inf...or the prevention of child,maltreatment., CDC,s n...lationships,(SSNR) as the foundation for a unified...
(Date:10/14/2008)...ker Founder and CEO Andrew Levitt to showcase Heal... Somerville, MA (PRWEB) Octob... , the word-of-mouth marketing (WOM) firm for the ... announced that Andrew Levitt, Founder and CEO of ...Pharma and Health 2.0" at Health 2.0: User-Ge...
(Date:10/14/2008)...PRNewswire-FirstCall/ -- Warner Chilcott,Limited (... its third quarter,2008 financial results prior to... In addition to issuing a press release, the Comp... parties on Monday, November 10, 2008 at,8:00 AM (...e in the call,please dial (877) 856-1955 in the U...
Breaking Medicine News(10 mins):Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 2Health News:National Family Partnership Designates October 27th 'Lock Your Meds' Day 3Health News:Los Angeles Psychologist to Help CDC Fight Child Abuse 2Health News:HealthTalker Founder and CEO Andrew Levitt to be Featured at 'Health 2.0: User-Generated Healthcare 2008' 2
...rsity of South Florida researchers report that a n...nd safe in clearing brain-damaging plaques from a ...mal, or across the skin, vaccination, may offer a ...devastating neurodegenerative disease with less li...
...and surgery appears to be an effective procedure t...new study conducted at NYU Medical Center. It is t...s under the age of 17, and it revealed that patien...ht by one year after surgery. The study is publish...
... with a history of abuse by intimate partners have...ization than women with no history of such abuse, ...Seattle-based health plan. The higher costs and u...use ended, the research team from Group Health, th...
...landmark in the series of release of Software Tool...ontemplated, //the Department of Information Techn...oftware tools and fonts in as many as seven Indian...e public. Shri.Maran, Minister of Communications ...
Other Medicine News:Health News:Transdermal Vaccine Effective in Treating Alzheimer's Disease in Mice 2Health News:Stomach Banding Surgery Effective for Adolescents 2Health News:Stomach Banding Surgery Effective for Adolescents 3Health News:Health Care Costs - Significant for Abused Women 2Health News:Software Tools & Fonts in Seven Indian Languages 2
(Date:10/10/2008)... Pivotal Data Show Prophylaxis Treatment with ...requent Bleeds in Children with No Pre-Existing,Jo.../ -- Bayer HealthCare LLC,announced today that the...ved routine prophylaxis with Kogenate(R) FS Antihe...ncy of bleeding episodes and the risk of,joint dam...
(Date:10/10/2008)... NATICK, Mass., Oct. 10 /PRNewswire-FirstCall/...day announced the schedule of the Company,s major,...ar Research Foundation,s,(CRF) twentieth annual Tr...ntific symposium, which runs from October 12 to 17...nnouncing a wide range of safety and,efficacy data...
(Date:10/9/2008)... North American Campaign to Spread Awareness a...SHINGTON, Oct. 9 /PRNewswire-USNewswire/ -- 133 mi...al care due to causes such as natural,disaster, ci...(SOS-USA) is,observing World Orphan Week by callin...o view the Multimedia News Release, go to:, http...
(Date:10/9/2008)... Company Prepares for Increased Sales and Market...rogress of MitraClip(R) System, MENLO PARK, Calif... in,the development of devices for the percutaneou... and marketing executive team with the appointment...ide sales and marketing and,Chris Richardson, as v...
Breaking Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference 15186 1New Study Same Result 21 Comprehensive Sex Education Works 15184 1New Study Same Result 21 Comprehensive Sex Education Works 15184 2Mens Health Guide for Ages 40 60 Launched by NHS Choices 15182 1PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call 4201 1PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call 4201 2
...ated for the treatment of plantar fasciitis and Ac...ply. The splint features adjustable dorsiflexion a... nightly contractures and tightening of the planta... flexibility in the treatment of the problem by al...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
... compression and cold, the Foot Cryo/Cuff minimize...ly designed cuff provides complete foot coverage f...ed as a single cuff, or with a cooler (including a... available separately and can be used with any mod...
Medicine Products: